Procter & Gamble Valuation Debate Heats Up After New Product Launch

Procter & Gamble (PG), the parent company of Pantene, is back in the financial spotlight after launching its new product, Cream to Mist. This leave-in spray was co-created with certified trichologist and social media advocate Abbey Yung. Procter & Gamble’s shares recently closed at US$144.91, with a 1-day return of 0.67%, though the 1-year total shareholder return is down 2.04%. This suggests that new product launches like Cream to Mist are occurring during a period of softer momentum. However, the 5-year total shareholder return stands at 16.25%, indicating steadier long-term growth.

The company’s recent returns hint at a cooler sentiment rather than a collapse in fundamentals. The key question now is whether the current share price aligns with underlying cash generation or reflects investor sentiment. According to Simply Wall Street, the most popular valuation narrative suggests that Procter & Gamble is 35% overvalued, with a fair value estimate of US$107.52, significantly below the recent close of US$144.91. This narrative frames the current share price as rich against the estimated fair value.

Despite this, Procter & Gamble’s business remains stable and predictable, though its stability comes with a high price tag at today’s quote. The valuation work suggests that most of the company’s quality is already reflected in the share price, meaning future returns depend heavily on investors continuing to pay a premium for that stability. However, stronger rival promotions or shifts in consumer preferences could challenge Procter & Gamble’s current valuation.

Alternatively, the Simply Wall Street Discounted Cash Flow (DCF) model presents a different view. It estimates Procter & Gamble’s fair value at US$196.96, suggesting that the current share price of US$144.91 is actually 26.4% undervalued. This discrepancy leaves investors questioning which set of assumptions is more realistic for a slow-growing staple giant like Procter & Gamble.